Search
for
Sort by
Research 541–570 of 1000+
- Congenital Hypotrichosis in Japanese White Strain (JW-NIBS) Rabbits.
- IL-17a induces age-related olfactory dysfunction by impairing regeneration and promoting respiratory metaplasia in mice
- Industry Updates from the Field of Stem Cell Research and Regenerative Medicine in December 2019
- Cutaneous Lupus Erythematosus
- Extracellular Signal-Regulated Kinase Mediates Ebastine-Induced Human Follicle Dermal Papilla Cell Proliferation
- Mechanism of PPARα agonist in alopecia areata
- 058 The pattern of Fas and Fas ligand expression in alopecia areata
- Tregs: Where We Are and What Comes Next?
- Alopecia areata - probing the deforestation
- In This Issue
- Alopecia universalis in a dog with testicular neoplasia
- Exploiting Unique Features of Microneedles to Modulate Immunity
- Immune-Epithelial Cross Talk in Regeneration and Repair
- FOXN1 deficient nude severe combined immunodeficiency
- COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
- Myeloproliferative disorder associated with alopecia universalis
- MCMV Infection Lowers the Threshold for the Development of Clinical GvHD after Allogeneic Bone Marrow Transplantation.
- Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
- Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease
- Omenn syndrome in a 10-month-old male with athymia and VACTERL association
- Trained Immunity and Local Innate Immune Memory in the Lung
- MicroRNA in skin diseases
- 15460 Perifollicular pink halo: A potential dermoscopic marker of inflammation in central centrifugal cicatricial alopecia
- A kindred with mutant IKAROS and autoimmunity
- Atlas of Geriatric Dermatology
- PŁYNY- NIE ZA DUŻO, NIE ZA MAŁO, LECZ W SAM RAZ
- Alopecia areata after mogamulizumab treatment
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- The role of WNT10B in physiology and disease: A 10-year update
- Decision‐Making Regarding the Administration of Live Vaccines to Patients With a <i>FOXN1</i> Heterozygous Missense Variant